Ewa Zembala‐Nożyńska

Fibronectin and Periostin as Prognostic Markers in Ovarian Cancer

Katarzyna Aleksandra Kujawa, Ewa Zembala‐Nożyńska, Alexander Jorge Cortez et al. · Cells · 2020 · 53 citations · Full text

Medicine, Oncology, Pathology +17

The Risk of Relapse in Papillary Thyroid Cancer (PTC) in the Context of BRAFV600E Mutation Status and Other Prognostic Factors

Agnieszka Czarniecka, Monika Kowal, Dagmara Rusinek et al. · PLoS ONE · 2015 · 41 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients

Dagmara Rusinek, Aleksandra Pfeifer, Jolanta Krajewska et al. · International Journal of Molecular Sciences · 2018 · 35 citations · Full text

Medicine, Oncology, Pathology +13

Establishment and Characterization of the Novel High-Grade Serous Ovarian Cancer Cell Line OVPA8

Patrycja Tudrej, Magdalena Olbryt, Ewa Zembala‐Nożyńska et al. · International Journal of Molecular Sciences · 2018 · 34 citations · Full text

Medicine, Cell Biology, Oncology +17

Molecular Composition of Serum Exosomes Could Discriminate Rectal Cancer Patients with Different Responses to Neoadjuvant Radiotherapy

Urszula Strybel, Łukasz Marczak, Marcin Zeman et al. · Cancers · 2022 · 31 citations · Full text

Life Sciences, Molecular Biology, Oncology +17